Literature DB >> 72581

Alpha-adrenergic blockers in prostatism.

P F Boreham, P Braithwaite, P Milewski, H Pearson.   

Abstract

Thirty patients awaiting prostatectomy with no history of cardiovascular disease were selected for a trial of alpha-adrenergic blocking agents. Twenty-seven patients completed the trial, 19 of them with unpleasant side effects. Eighteen of them found their symptoms were improved and 10 showed urodynamic improvement.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 72581     DOI： 10.1002/bjs.1800641019

Source DB:  PubMed          Journal:  Br J Surg        ISSN： 0007-1323            Impact factor:   6.939


  5 in total

Review 1.  Current concepts in the treatment of genitourinary tract disorders in the older individual.

Authors:  A Atala; M Amin
Journal:  Drugs Aging       Date:  1991-05       Impact factor: 3.923

Review 2.  Alpha-adrenoceptor antagonists in the treatment of benign prostatic hyperplasia.

Authors:  K L Cooper; J M McKiernan; S A Kaplan
Journal:  Drugs       Date:  1999-01       Impact factor: 9.546

3.  Symptomatic treatment of benign prostatic obstruction with nicergoline: a placebo controlled clinical study and urodynamic evaluation.

Authors:  F Ronchi; A Margonato; R Ceccardi; P Rigatti; B M Rossini
Journal:  Urol Res       Date:  1982

Review 4.  Benign prostatic hyperplasia. Current pharmacological treatment.

Authors:  M Jønler; M Riehmann; R C Bruskewitz
Journal:  Drugs       Date:  1994-01       Impact factor: 9.546

5.  Electrical and mechanical properties of the capsular smooth muscles of the rabbit prostate in relation to the actions of the alpha 1-adrenoceptor blocker, YM-12617.

Authors:  N Seki; E Nishiye; T Itoh; H Suzuki; H Kuriyama
Journal:  Br J Pharmacol       Date:  1988-03       Impact factor: 8.739
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.